COVID-19: Information to support prescribers, dispensers and healthcare consumers

The coronavirus (COVID-19) situation is evolving, and advice is being regularly updated by the Australian Government and state and territory health departments.

On this page we have evidence-based information for healthcare consumers and for healthcare professionals.

Quality use of medicines and COVID-19: information for health professionals

Latest evidence: managing COVID-19

03 Sep 2020

Report suggests dexamethasone reduces mortality in patients seriously ill with COVID-19

11 Jun 2020

NPS MedicineWise partners with National COVID-19 Clinical Evidence Taskforce

04 Jun 2020

Hydroxychloroquine and COVID-19

22 May 2020

Antiviral medicines and the treatment of COVID-19

Quality prescribing

06 Aug 2020

COVID-19 information translated into community languages

Links to reliable information about COVID-19 in a range of languages other than English

Find out more

03 Jul 2020

Heart Foundation health professional webinar: Optimising care for people with CVD during COVID-19

21 May 2020

Changes to electronic prescribing

21 May 2020

PBS restriction criteria lifted for some medicines

07 May 2020

Asthma diagnosis and treatment during the COVID-19 pandemic

Podcast

NPS MedicineWise · Episode 14: Managing diabetes during COVID-19

Stay up to date with latest evidence for medicines, tests and treatments, during the COVID-19 pandemic.

Hosted by a rotating group of interviewers including our CEO and pharmacist, Adj A/Prof Steve Morris, and GP and NPS MedicineWise medical adviser Dr Anna Samecki, we’ll wade through the reams of information – and sometimes misinformation – to provide answers from trusted sources for quality use of medicines questions.

Listen to previous episodes

National COVID-19 Clinical Evidence Taskforce recommendations

NPS MedicineWise is a partner to the work of the National COVID-19 Clinical Evidence Taskforce (the Taskforce) which is producing ‘living’ guidelines to support front-line clinicians with reliable and up-to-date advice on the latest evidence.

Members of the Taskforce include peak health professional bodies whose members are providing clinical care to people with COVID-19, and the guidelines are specific to managing COVID-19 across mild, moderate, severe and critical illness.

For the latest guidance please visit the Taskforce website https://covid19evidence.net.au/#living-guidelines

NPS MedicineWise is supporting the work of the Taskforce by helping clinicians to understand how to implement relevant guidelines into clinical practice. This includes publication of evidence summaries on medicines and tests, and working through Choosing Wisely Australia to support implementation into healthcare protocols and systems.